Amanda Drury , Kristen L. Fessele , Piera Robson , Ethel Law , Margaret Barton-Burke , Bridgette Thom
{"title":"Exploring research engagement among nurses in a Magnet®-recognized cancer center: An analysis of knowledge, attitudes, practices, and influencing factors","authors":"Amanda Drury , Kristen L. Fessele , Piera Robson , Ethel Law , Margaret Barton-Burke , Bridgette Thom","doi":"10.1016/j.apjon.2024.100545","DOIUrl":"10.1016/j.apjon.2024.100545","url":null,"abstract":"<div><h3>Objective</h3><p>Despite the significance of research in nursing practice and its role in enhancing the quality of life for cancer patients, nurses report limited opportunities to engage with research. Known barriers include limited organizational support, a lack of time, resources, and knowledgeable colleagues/mentors. The study aims to determine research knowledge, attitudes, and practices among cancer nurses and understand factors influencing nurses’ involvement in research.</p></div><div><h3>Methods</h3><p>Registered nurses responded to a cross-sectional questionnaire. Data were collected using a modified version of the Nursing Research Knowledge, Attitudes, and Practices survey and the Barriers to Nurses’ Participation in Research Questionnaire.</p></div><div><h3>Results</h3><p>Three hundred and sixty-six nurses responded, of whom 15% had previously been involved in research. Nurses reported moderate to high research knowledge (<span><math><mrow><mi>μ</mi><mo>=</mo></mrow></math></span> 1.72), attitudes (<span><math><mrow><mi>μ</mi><mo>=</mo></mrow></math></span> 1.92), and practice (<span><math><mrow><mi>μ</mi><mo>=</mo></mrow></math></span> 1.79) scores. The most common barriers to engagement with research included a lack of time (78.0%), lack of incentive or reward (61.4%), lack of knowledge or skills (54.2%), lack of training opportunities (51.4%), and lack of experienced nursing research mentors (44.8%). Holding a specialist, advanced practice, or administrative role, and a postgraduate qualification were associated with higher scores on the knowledge, attitudes and practice subscales. Previous experience of conducting research was associated with higher knowledge and attitudes scores. Previous experience of authoring a paper and submitting a grant were associated with higher knowledge scores.</p></div><div><h3>Conclusions</h3><p>The study reveals a moderate–to-high level of knowledge, attitudes, and practice regarding research among nurses, but low engagement. Barriers include lack of time, incentive, knowledge, training, and mentorship. Nevertheless, attitude scores, reflecting nurses’ willingness to engage in research were high on average. The findings highlight the potentially modifiable nature of barriers to research engagement. Increasing capacity for nursing research may be achieved through investment in research support and training to overcome barriers to research, which may discourage nurses engagement.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001677/pdfft?md5=d48fb8d8efbb026d7414769fb8fec185&pid=1-s2.0-S2347562524001677-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141978339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cancer care management for patients with intellectual disabilities, Alzheimer's disease, and related dementias","authors":"","doi":"10.1016/j.apjon.2024.100534","DOIUrl":"10.1016/j.apjon.2024.100534","url":null,"abstract":"","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001562/pdfft?md5=62e83962026e766912f0a57bc9816606&pid=1-s2.0-S2347562524001562-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141413342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Symptom experiences and self-management strategies of patients with haematological malignancy undergoing chemotherapy: A qualitative study","authors":"Hui Yang , Bizhao Wu , Rong Hu , Ying Wang","doi":"10.1016/j.apjon.2024.100563","DOIUrl":"10.1016/j.apjon.2024.100563","url":null,"abstract":"<div><h3>Objective</h3><p>To explore symptom experiences and self-management strategies from the haematological malignancy patient's perspective.</p></div><div><h3>Methods</h3><p>A qualitative descriptive approach was used to provide a direct and comprehensive understanding of the symptoms experienced and self-management strategies during treatment among patients with haematological malignancy. Fourteen patients with haematologic malignancies who received chemotherapy at a Chinese tertiary hospital were selected using purposeful sampling. Data were collected via semi-structured interviews and one-on-one patient sessions. The collected data were analysed using the content analysis methods. Reporting adhered to the COnsolidated criteria for REporting Qualitative research (COREQ) guidelines.</p></div><div><h3>Results</h3><p>The data from this study were categorized into four themes and eight subthemes: (1) the dynamics and complexity of symptom experience (nonlinear, and overloaded symptom burden); (2) strategies for coping with symptomatic change (actively responding to challenges, and facing symptoms negatively); (3) symptom affects interaction (symptoms affect family interactions, and symptoms affect social interactions); and (4) benefit from symptom management (promoting family relationships, and regaining a new role in society).</p></div><div><h3>Conclusions</h3><p>Patients with haematological malignancy undergoing chemotherapy still face complex and variable symptoms, and there are still considerable challenges in symptom management. The findings underscore that health care providers should provide the necessary symptom assessment to enhance the well-being of patients based on the characteristics of the patient's symptom experience and symptom management needs at different stages of the disease.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001859/pdfft?md5=ad1850ff107f6c35cb692f276c0bc82c&pid=1-s2.0-S2347562524001859-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141990361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xiaocen Chen , Xueyu Li , Zhao Wang , Ruishuang Zheng , Fang Zhang , Jing Zhao , Huiying Liu , Hongyuan Luo
{"title":"Evidence-based summary of the prevention and management of radiation dermatitis in patients with breast cancer","authors":"Xiaocen Chen , Xueyu Li , Zhao Wang , Ruishuang Zheng , Fang Zhang , Jing Zhao , Huiying Liu , Hongyuan Luo","doi":"10.1016/j.apjon.2024.100556","DOIUrl":"10.1016/j.apjon.2024.100556","url":null,"abstract":"<div><h3>Objective</h3><p>Up to now there is a lack of research to summarize the relevant evidence for radiation dermatitis (RD) management in patients with breast cancer. Therefore, this study aimed to summarize the best evidence for the prevention and management of RD in patients with breast cancer.</p></div><div><h3>Methods</h3><p>According to the “6S” evidence pyramid model, all major databases were searched from January 2018 to February 2024: UpToDate, BMJ Best Practice, National Guideline Clearinghouse, Guidelines International Network, MedSci, Yi Maitong Guidelines, National Comprehensive Cancer Network, Oncology Nursing Society, Radiology Assistant database, Society and College of Radiographers, Australian JBI Evidence-Based Health Care Center database, Cochrane Library, PubMed, CINAHL, Embase, Web of Science, China National Knowledge Infrastructure, Wangfang Data, Chinese Science and Technology Journal Database, Chinese Biology Medicine, etc.</p></div><div><h3>Results</h3><p>A total of 22 articles which met the inclusion criteria were included in the study, comprising six guidelines, nine systematic reviews, four evidence summaries, one clinical decision, one expert consensus, and one randomized controlled trial. We summarized 35 pieces of evidence across four aspects: influence factor, evaluation and monitoring, prevention and treatment, care and health education.</p></div><div><h3>Conclusions</h3><p>This study provides a comprehensive summary of the best evidence for the prevention and management of RD in patients with breast cancer. It is recommended that subsequent evidence transformation should be conducted based on specific clinical circumstances to standardize the process of clinical prevention and management of RD.</p></div><div><h3>Systematic review registration</h3><p>This study was registered at the Fudan University Center for Evidence-Based Nursing (Registration No. ES20244311).</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001781/pdfft?md5=23f544d83ff5da85f169acece657b5c0&pid=1-s2.0-S2347562524001781-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141702374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Feixia Ni , Tingting Zhou , Lili Wang , Tingting Cai
{"title":"Intimate partner violence in women with cancer: An integrative review","authors":"Feixia Ni , Tingting Zhou , Lili Wang , Tingting Cai","doi":"10.1016/j.apjon.2024.100557","DOIUrl":"10.1016/j.apjon.2024.100557","url":null,"abstract":"<div><h3>Objective</h3><p>This study aims to estimate the incidence of intimate partner violence (IPV) among women cancer survivors and identify associated factors.</p></div><div><h3>Methods</h3><p>Using Whittemore and Knafl's integrative review method, we synthesized literature on the association between IPV and cancer in women.</p></div><div><h3>Results</h3><p>We conducted a comprehensive search of literature published between 2003 and 2024 across eight databases, resulting in 24 English-language articles. These articles included qualitative, quantitative, and mixed-method studies. Our synthesis identified several factors influencing the relationship between IPV and cancer, including sociodemographic factors (e.g., age and income), health-related factors, lifestyle-related factors (such as life experiences and interpersonal relationships), cancer-related factors (including type and treatment), and cancer screening behaviors.</p></div><div><h3>Conclusions</h3><p>The study highlights that various factors contribute to the prevalence of IPV among women with cancer. Particularly vulnerable are younger patients, those with lower incomes, and those with more severe disease manifestations. Healthcare professionals should assess for IPV risk during medical consultations and ensure access to appropriate support services.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001793/pdfft?md5=9e68abd714e9d4395802517181d437cf&pid=1-s2.0-S2347562524001793-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141711921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Remembering Judi - The neighborly grandmother who spread hope","authors":"Jingmin Hu","doi":"10.1016/j.apjon.2024.100555","DOIUrl":"10.1016/j.apjon.2024.100555","url":null,"abstract":"","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S234756252400177X/pdfft?md5=20eb3157795c1d8a958e7b68af28d4a9&pid=1-s2.0-S234756252400177X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141696358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Weichao Liu , Liping Wang , Dijuan Meng , Chengang Hong , Qianyu Zhang , Jinghan Yang
{"title":"Effectiveness of topical corticosteroids on the prevention of acute radiation dermatitis in patients with breast cancer: An updated systematic review and meta-analysis","authors":"Weichao Liu , Liping Wang , Dijuan Meng , Chengang Hong , Qianyu Zhang , Jinghan Yang","doi":"10.1016/j.apjon.2024.100553","DOIUrl":"10.1016/j.apjon.2024.100553","url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate the effect of topical corticosteroids (TCS) in preventing acute radiation dermatitis in patients with breast cancer.</p></div><div><h3>Methods</h3><p>An updated systematic review and meta-analysis were conducted following the preferred reporting items for systematic reviews and meta-analyses. Randomized controlled trials (RCTs) in six English databases (PubMed, Web of Science, Scopus, CINAHL, Cochrane Library, Embase), three Chinese databases (Sinomed, China National Knowledge Infrastructure, Cqvip), and two clinical trial registration platforms (CHICTR, <span><span>Clinicaltrials.gov</span><svg><path></path></svg></span>) were systematically searched from inception to 1 February 2024.</p></div><div><h3>Results</h3><p>Thirteen RCTs were included, with 1172 patients in this updated review. Meta-analysis showed that TCS reduced the rate of moist desquamation (OR = 0.31; 95% CI = [0.22, 0.44]; <em>P</em> < 0.01), the incidence of Radiation Therapy Oncology Group ratings of grade 2 or higher (OR = 0.22; 95% CI = [0.14, 0.32]; <em>P</em> < 0.01), the incidence of Common Terminology Criteria for Adverse Events ratings of grade 2 or higher (OR = 0.56; 95% CI = [0.37, 0.84]; <em>P</em> < 0.01), the mean score of radiation dermatitis (SMD = −0.46; 95% CI = [−0.59, −0.34]; <em>P</em> < 0.01), skin erythema and hyperpigmentation readings, and improved subjective symptoms.</p></div><div><h3>Conclusions</h3><p>TCS can effectively prevent acute radiation dermatitis in patients with breast cancer.</p></div><div><h3>Systematic review registration</h3><p>Prospero (CRD42024507890).</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001756/pdfft?md5=6ad9c4e7c70cbf74622274d3b57cb3ee&pid=1-s2.0-S2347562524001756-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141695996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lingling Wang , Ruiqi Sun , Lidan Tian , Richard Huan Xu
{"title":"Influence of age on financial toxicity in cancer patients","authors":"Lingling Wang , Ruiqi Sun , Lidan Tian , Richard Huan Xu","doi":"10.1016/j.apjon.2024.100552","DOIUrl":"10.1016/j.apjon.2024.100552","url":null,"abstract":"<div><h3>Objective</h3><p>The aim of this study was to assess the level of financial toxicity (FT) experienced by the following three age groups of cancer patients in China: young working-aged patients (age < 40 years), middle-aged patients (40–64 years), and older patients (≥ 65 years).</p></div><div><h3>Methods</h3><p>The data used for this study were collected via a cross-sectional survey conducted in China. FT was assessed using the Comprehensive Score for Financial Toxicity (COST). ANOVA was used to examine the differences in FT status between age groups. Multivariate linear regression models were employed to assess the association between age and FT, adjusted by socioeconomic and other clinical characteristics.</p></div><div><h3>Results</h3><p>A total of 556 cancer patients completed the survey. Approximately 54.3% of the participants were male and 45.7% were female. The majority (61.5%) were aged 40–64 years, while 27.7% were aged 65 or older. The mean FT scores for young patients (< 40 years), middle-aged patients (40–64 years), and older patients (≥ 65 years) were 16.7, 12.8, and 12.4, respectively. The results of the regression analysis revealed that, without adjusting for background characteristics, young patients had significantly higher mean COST scores. This suggests they experienced lower levels of FT compared to patients in other age groups. Stratified analysis revealed that, for older patients, only educational level and type of insurance scheme were significant factors in predicting the COST score.</p></div><div><h3>Conclusions</h3><p>This study provides empirical evidence for developing targeted interventions and policies to reduce the FT for patients in different age groups. Given that FT is complicated, a longitudinal study should be conducted to explore the long-term impact of FT on cancer patients' quality of life and well-being.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001744/pdfft?md5=3959b32187c19fad61d30a1ba59f8e04&pid=1-s2.0-S2347562524001744-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141693973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Updates and emerging trends in the management of immune-related adverse events associated with immune checkpoint inhibitor therapy","authors":"Ninh M. La-Beck, Jesuwapelumi Owoso","doi":"10.1016/j.apjon.2024.100549","DOIUrl":"10.1016/j.apjon.2024.100549","url":null,"abstract":"<div><p>The rapidly expanding class of therapies targeting immune checkpoints for the treatment of various cancers now includes 8 clinically approved agents: a lymphocyte-activation gene 3 (LAG-3) inhibitor (relatlimab), a cytotoxic T lymphocyte associated protein 4 (CTLA-4) inhibitor (ipilimumab), three programmed cell death protein 1 (PD-1) inhibitors (nivolumab, pembrolizumab and cemiplimab), and three programmed cell death ligand-1 (PD-L1) inhibitors (atezolizumab, durvalumab, and avelumab). Previously, we reviewed the mechanisms of immune-related adverse events (irAEs), strategies for management of irAEs, and highlighted similarities as well as differences amongst clinical guidelines from the National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO), Society for Immunotherapy of Cancer (SITC), and European Society for Medical Oncology (ESMO). Herein, we provide an update that includes discussion of changes to these clinical guidelines since our last review, the new LAG-3 targeted agents, emerging patterns of irAEs, and new directions for improved monitoring and treatment of irAEs that could incorporate interdisciplinary pharmacist-led teams, artificial intelligence, and pharmacogenomics.</p></div>","PeriodicalId":8569,"journal":{"name":"Asia-Pacific Journal of Oncology Nursing","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2347562524001719/pdfft?md5=7ff6f74b9a4165f178464fc976e4a9bf&pid=1-s2.0-S2347562524001719-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141690142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}